학술논문
Dipeptidyl peptidase‐4 inhibitors increase the risk of bullous pemphigoid in older patients with diabetes: A retrospective analysis using the Korean National Health Insurance Database.
Document Type
Article
Author
Source
Subject
*NATIONAL health insurance
*CD26 antigen
*OLDER patients
*BULLOUS pemphigoid
*PEOPLE with diabetes
*DATABASES
*
*
*
*
*
Language
ISSN
0926-9959
Abstract
Dipeptidyl peptidase-4 inhibitors increase the risk of bullous pemphigoid in older patients with diabetes: A retrospective analysis using the Korean National Health Insurance Database 2020; 111: 249 - 53. 7 Kridin K. Dipeptidyl-peptidase IV inhibitors (DPP4i)-associated bullous pemphigoid: estimating the clinical profile and exploring intraclass differences. Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation. [Extracted from the article]